Price
$21.41+32.41%Social Signal Score
Analyst Ratings
41 analystsRevenue
$820.89M+376.60%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Scott Brinker
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- Employees
- 411
- Beta
- 0.99
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 0.39
Financials
Revenue
$820.89M+376.6%Net Income
$17.26M-70.6%EBITDA
$420.80MFree Cash Flow
$324.02M+50.4%EPS (diluted)
$0.02-83.3%Shares Outstanding (diluted)
689.51M+47.3%Operating Expenses
$23.59MCash & Debt
$514.31MReturn of Capital
$210.39MRevenue by Segment (annual)
$2.74BDividend per Share
$0.10Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $2.82B | $71.35M | $0.10 |
| 2024 | $2.70B | $243.14M | $0.36 |
| 2023 | $2.18B | $306.01M | $0.56 |
| 2022 | $2.06B | $500.45M | $0.92 |
| 2021 | $1.90B | $505.54M | $0.93 |
| 2020 | $1.64B | $413.56M | $0.77 |
| 2019 | $1.24B | $45.53M | $0.09 |
| 2018 | $1.19B | $1.06B | $2.25 |
| 2017 | $1.85B | $414.17M | $0.88 |
| 2016 | $2.13B | $627.75M | $1.34 |
| 2015 | $1.94B | $-559.24M | $-1.21 |
| 2014 | $1.64B | $922.23M | $2.01 |
| 2013 | $2.10B | $970.84M | $2.13 |
| 2012 | $1.88B | $832.54M | $1.90 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from DOC's reported EPS growth of -20.3% a year over 13 years. Historical EPS growth of -20% would project the company towards zero. Floored at -15% as a starting point.
- EPS in 5 years
- $0.05
- Implied price
- $0.82
- Return from $19.34
- -46.9% a year
To earn 15.0% a year on these assumptions you'd need to buy at $0.41 — -97.9% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -25.0% | -56.8% | -54.8% | -53.1% | -51.7% | -50.3% |
| -20.0% | -53.9% | -51.8% | -50.0% | -48.4% | -47.0% |
| -15.0% | -51.0% | -48.8% | -46.9% | -45.2% | -43.7% |
| -10.0% | -48.1% | -45.8% | -43.7% | -42.0% | -40.4% |
| -5.0% | -45.2% | -42.7% | -40.6% | -38.8% | -37.1% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
50+0.00%Social Signal Score
Mentions (23)
- 4chan /biz/biz·5d ago·Neutral
>>62920740 IN ENGLISH DOC
View source ↗ - News (RSS)seekingalpha·10d ago·Neutral
Healthpeak Properties' Scavenger Mentality
View source ↗ - 4chan /biz/biz·10d ago·Positive
…Jensen did not go public on this own, he was contacted by a reporter who was going to make it public. It could be Jensen was falling too deep into the p**** trap and DOC could not allow Jensen to hand over the keys of the technology or secret back doors.
View source ↗ - 4chan /biz/biz·12d ago·Neutral
>>62882955 ENGLISH DOC!
View source ↗ - 4chan /biz/biz·13d ago·Neutral
>>62880748 IN PLAIN ENGLISH DOC!
View source ↗ - News247wallst.com·13d ago·Neutral
Doctors' Offices, Labs and Nursing Homes Pay Rent to These 3 REITs, and $150,000 Yields $8,510 a Year Every clinic visit, rehab stay, and lab experiment ends with a rent check, and three healthcare landlords collect it. One has already cut its dividend twice, and another leans on Medicare dollars.
View source ↗ - Newsseekingalpha.com·18d ago·Positive
Healthpeak Properties: FFO Is Down, But The Best Is Yet To Come Healthpeak Properties is a 5% portfolio position, driven by a bullish multi-year Life Science turnaround thesis and acquisition-led growth potential. Q3 2026 guidance was revised upward, with the FFO midpoint now $1.77 and the FFO payout ratio improving to 69%, reflecting operational resilience. Lab segment occupancy increased 130 bps sequentially, with year-over-year same-store NOI trending toward positive territory, supporting fut…
View source ↗ - Newsseekingalpha.com·18d ago·Positive
…etup Healthpeak Properties is reiterated as a Buy, driven by resilient earnings, another guidance boost, and a compelling valuation offering a good margin of safety. DOC's Lab segment shows signs of stabilization and potential rebound, supported by strong occupancy gains and positive leasing momentum. Outpatient Medical and Senior Housing segments deliver robust growth, with Senior Housing posting a 25.9% NOI increase amid very strong performance from Janus Living.
View source ↗ - Newsmarketbeat.com·18d ago·Positive
What Healthpeak Properties (DOC) Said on Its Q3 Earnings Call Healthpeak Properties NYSE: DOC raised its full-year earnings outlook for the third time in 2026 after reporting what President and Chief Executive Officer Scott Brinker described as a strong operational quarter across outpatient medical, life science and senior housing.
View source ↗ - Newszacks.com·19d ago·Positive
Healthpeak's Q3 FFOA Beat Estimates on Leasing, Senior Housing Growth DOC's Q3 2026 FFOA and revenues beat estimates, driven by solid outpatient leasing and senior housing growth, prompting an upgraded full-year FFOA outlook.
View source ↗ - Newszacks.com·20d ago·Neutral
Healthpeak (DOC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates Although the revenue and EPS for Healthpeak (DOC) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
View source ↗ - Newszacks.com·20d ago·Positive
Healthpeak (DOC) Q3 FFO and Revenues Surpass Estimates Healthpeak (DOC) came out with quarterly funds from operations (FFO) of $0.44 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to FFO of $0.46 per share a year ago.
View source ↗ - Newszacks.com·24d ago·Positive
What's in the Cards for Healthpeak Properties This Earnings Season? DOC is set to report Q3 earnings, with revenue growth expected to offset FFOA declines amid strong senior housing demand and lab market challenges.
View source ↗ - News (RSS)zerohedge·26d ago·Neutral
…liticians may have been secretly filmed engaging in sexual activity with minors.THIS is what @Comey and his daughter are hiding in New York. https://t.co/tocnjabzj6— DOC (@doctormalibu) February 28, 2025* * *For your consideration from ZH Store:ZeroHedge MultitoolZeroHedge Dark Roast CoffeeZeroHedge ShirtIQ Biologix AstaxanthinZeroHedge HatIQ Biologix ColostrumThanks for your support Tyler Durden Mon, 10/26/2026 - 23:25
View source ↗ - Newsseekingalpha.com·41d ago·Neutral
Healthpeak Properties: High Yield, Strong Balance Sheet, And Upside Potential Healthpeak Properties offers a compelling 6.5% monthly dividend yield, supported by a BBB+ balance sheet and well-covered payout ratio. DOC trades at 10.65x forward FFO, well below its historical P/FFO of 14.0, presenting an attractive entry point after a recent dip. Outpatient medical and senior housing segments deliver steady results, while life science occupancy shows early signs of recovery amid sector headwinds.
View source ↗ - News247wallst.com·46d ago·Neutral
Healthpeak Properties: Can This Healthcare REIT Keep Funding Its Dividend Healthpeak's 6.
View source ↗ - Newsbusinesswire.com·52d ago·Neutral
…ealthpeak Properties Announces Dates of Third Quarter 2026 Earnings Release, Conference Call, and Webcast DENVER--(BUSINESS WIRE)--Healthpeak Properties, Inc. (NYSE: DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, is scheduled to report third quarter 2026 financial results after the close of trading on the New York Stock Exchange on Monday, November 2, 2026. Healthpeak will host a conference call and webcast on Tuesday, November 3, 2026, at 10…
View source ↗ - News (RSS)fool·57d ago·Neutral
This Dividend Stock Pays You 12 Times Per Year. Here's What a $25,000 Investment Deposits Each Month. Healthpeak is a rare S&P 500 stock that pays a monthly dividend.
View source ↗ - Newsseekingalpha.com·67d ago·Positive
Healthpeak Properties: Buy Reaffirmed As Outpatient And Senior Portfolio Shows Proven Performance Healthpeak gets its prior buy from Oct. 2025 reaffirmed. Positives include a supportive macro environment, dividend coverage and high yield, an investment-grade rating, and leasing growth in Q2. Selective diversification is spread across outpatient, lab, and senior housing across a geographically diverse scale.
View source ↗ - Newsprnewswire.com·74d ago·Neutral
PROSECCO DOC CELEBRATES THE SUCCESS OF "UNCORKING PROSECCO DOC 2026" IN SEOUL, ENGAGING MORE THAN 35 RESTAURANTS AND FORGING NEW PARTNERSHIPS IN ART AND FASHION /PRNewswire/ -- Prosecco DOC has brought a taste of the Italian lifestyle to Seoul's vibrant culinary scene with their new campaign, "Uncorking Prosecco DOC
View source ↗ - Newsglobenewswire.com·82d ago·Neutral
Healthpeak Properties, Inc. (NYSE: DOC) President and CEO Scott Brinker Interviewed by Advisor Access SAN FRANCISCO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Healthpeak Properties, Inc. (NYSE: DOC) is a fully integrated real estate investment trust (REIT) and S&P 500 company.
View source ↗ - Newszacks.com·104d ago·Negative
Is the Options Market Predicting a Spike in Healthpeak Properties Stock? Investors need to pay close attention to DOC stock based on the movements in the options market lately.
View source ↗ - Newsmarketbeat.com·106d ago·Neutral
Healthpeak Properties Q2 Earnings Call Highlights Healthpeak Properties NYSE: DOC reported second-quarter adjusted funds from operations of $0.46 per share and raised its full-year adjusted FFO guidance by $0.02 to a range of $1.73 to $1.77 per share, citing improved same-store net operating income expectations in its lab and senior housing businesses.
View source ↗
Earnings
Mon, Feb 1(in 2 months)
Consensus estimate $0.04 per share
Typical surprise -21.9% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Nov 2$0.02 vs $0.06miss
- Tue, Aug 4$0.08 vs $0.03beat
- Tue, May 5$0.28 vs $0.05beat
- Mon, Feb 2$0.16 vs $0.45miss
- Thu, Oct 23$-0.17 vs $0.06miss
- Thu, Jul 24$0.05 vs $0.06miss
Estimates and results for DOC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by DOC officers and directors.
- Bought
- $1.1m
- Sold
- $341k
14 trades
2 trades
- Patadia Ankit B.sold
- Bohn Scott Rsold
- Thomas John Tbought
- Brinker Scott Mbought
- Brinker Scott Mbought
- Brinker Scott Mbought
- Thompson Tommy Gbought
- Thompson Tommy Gbought
84 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Alan Armstrongsenate · disclosed Jul 21, 2026 (116d later)Buy$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Feb 13, 2026 (35d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Sep 15, 2025 (42d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (57d later)Buy$1,001 - $15,000
- Robert P. Bresnahanhouse · PA08 · disclosed Jun 10, 2025 (26d later)Sell$1,001 - $15,000
- Julie Johnsonhouse · TX32 · disclosed May 15, 2025 (44d later)Sell$1,001 - $15,000
- Chris Jacobshouse · NY27 · disclosed Jan 20, 2023 (39d later)Buy$1,001 - $15,000
- Chris Jacobshouse · NY27 · disclosed Dec 12, 2022 (34d later)Sell$1,001 - $15,000
- Chris Jacobshouse · NY27 · disclosed Sep 9, 2022 (53d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
